Dable Habib J — SEC Form 4 filings

SEC reporting owner CIK 1690773. 17 Form 4 filings on record with FilingPulse; latest filed 2026-06-22.

Transaction summary — filings shown

Covers all 17 filings on record, filed 2024-01-19 to 2026-06-22. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Day One Biopharmaceuticals, Inc. (DAWN)Director512
Blueprint Medicines Corp (BPMC)Director38
PepGen Inc. (PEPG)Director33
Aerovate Therapeutics, Inc. (AVTE)Director22
Relay Therapeutics, Inc. (RLAY)Director22
SpyGlass Pharma, Inc. (SGP)Director11
Tyra Biosciences, Inc. (TYRA)Director11

Form 4 filings — Dable Habib J

FiledFormIssuerReported transactionsSource
2026-06-224PepGen Inc. (PEPG)Grant/award (A): 34,000 (derivative) @ $0EDGAR
2026-06-104Relay Therapeutics, Inc. (RLAY)Grant/award (A): 32,947 (derivative) @ $0EDGAR
2026-04-234Day One Biopharmaceuticals, Inc. (DAWN)Disposition to issuer (D): 66,660 (derivative) · Disposition to issuer (D): 32,335 (derivative) · Disposition to issuer (D): 22,500 (derivative) · Disposition to issuer (D): 15,000 (derivative)EDGAR
2026-04-204Tyra Biosciences, Inc. (TYRA)Grant/award (A): 44,400 (derivative) @ $0EDGAR
2026-02-094SpyGlass Pharma, Inc. (SGP)Grant/award (A): 27,400 (derivative) @ $0EDGAR
2025-11-074Day One Biopharmaceuticals, Inc. (DAWN)Disposition to issuer (D): 66,660 (derivative) @ $0 · Grant/award (A): 66,660 (derivative) @ $0 · Disposition to issuer (D): 32,335 (derivative) @ $0 · Grant/award (A): 32,335 (derivative) @ $0EDGAR
2025-11-064Relay Therapeutics, Inc. (RLAY)Grant/award (A): 207,931 (derivative) @ $0EDGAR
2025-07-214Blueprint Medicines Corp (BPMC)Disposition to issuer (D): 3,902 · Code (U): 8,742 · Disposition to issuer (D): 7,950 (derivative) · Disposition to issuer (D): 5,300 (derivative) · Disposition to issuer (D): 4,570 (derivative)EDGAR
2025-06-244Blueprint Medicines Corp (BPMC)Grant/award (A): 3,902 @ $128.12EDGAR
2025-06-064PepGen Inc. (PEPG)Grant/award (A): 16,000 (derivative) @ $0EDGAR
2025-06-044Day One Biopharmaceuticals, Inc. (DAWN)Grant/award (A): 22,500 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0EDGAR
2024-06-214PepGen Inc. (PEPG)Grant/award (A): 13,000 (derivative) @ $0EDGAR
2024-06-144Blueprint Medicines Corp (BPMC)Grant/award (A): 2,242 @ $0 · Grant/award (A): 4,570 (derivative) @ $0EDGAR
2024-06-074Aerovate Therapeutics, Inc. (AVTE)Grant/award (A): 12,500 (derivative) @ $0EDGAR
2024-05-284Day One Biopharmaceuticals, Inc. (DAWN)Grant/award (A): 32,335 (derivative) @ $0EDGAR
2024-03-064Aerovate Therapeutics, Inc. (AVTE)Grant/award (A): 1,531 (derivative) @ $16.37EDGAR
2024-01-194Day One Biopharmaceuticals, Inc. (DAWN)Grant/award (A): 66,660 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1690773 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →